This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Honolulu (Hawaii) Heart Program

Grant N. Stemmermann, MD; Po-Huang Chyou, PhD; Abraham Kagan, MD; Abraham M. Y. Nomura, MD; Katsuhiko Yano, MD

Arch Intern Med. 1991;151(5):969-972.

Abstract
Hawaiian men of Japanese ancestry followed up for 18 or more years after a baseline examination showed a quadratic distribution of death rates at different levels of serum cholesterol. Mortality from cancer progressively decreased and mortality from coronary heart disease progressively increased with rising levels of serum cholesterol. There was a positive association between baseline serum cholesterol levels and deaths from coronary heart disease at 0 to 6 years, 7 to 12 years, and 13 years and longer after examination. The inverse relationship between cancer and serum cholesterol levels was stronger in the first 6 years than in the next 6 years and, although still inverse, lost statistical significance after 13 years. Cancers of the colon and lung showed the strongest association with low baseline serum cholesterol levels, while gastric or rectal cancer failed to show this association. Organ specificity and persistence of the inverse association beyond 6 years suggest that the nutritional demands of cancers may not entirely explain the inverse association with some cancers. The quadratic distribution of deaths in this cohort remained after coronary heart disease, stroke, and cancer were removed from the analysis. For the entire period of observation, the lowest mortalities were found in men with serum cholesterol levels between 4.65 and 6.18 mmol/L (between 180 and 239 mg/dL). Manipulation of serum cholesterol levels below this level would not be desirable if this were to result in increased risk of death from cancer or other disease. This study does not rule out this possibility.

(Arch Intern Med. 1991;151:969-972)

Author Affiliations
From the Japan-Hawaii Cancer Study, Honolulu, Hawaii.

Footnotes
Accepted for publication October 15, 1990.

Reprint requests to Japan-Hawaii Cancer Study, 347 N Kuakini St, Honolulu, HI 96817 (Dr Stemmermann).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study
Sritara et al.
ANGIOLOGY 2008;58:757-763.
ABSTRACT  

Statins and Cancer Risk: A Literature-Based Meta-Analysis and Meta-Regression Analysis of 35 Randomized Controlled Trials
Bonovas et al.
JCO 2006;24:4808-4817.
ABSTRACT | FULL TEXT  

Lipids for Psychiatrists - an overview
Young
J Psychopharmacol 2005;19:66-75.
ABSTRACT  

Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy: A PROVE IT-TIMI 22 Substudy
Wiviott et al.
J Am Coll Cardiol 2005;46:1411-1416.
ABSTRACT | FULL TEXT  

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
J Am Coll Cardiol 2004;44:720-732.
ABSTRACT | FULL TEXT  

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:e149-e161.
ABSTRACT | FULL TEXT  

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
Circulation 2004;110:227-239.
ABSTRACT | FULL TEXT  

Role of risk factors for major coronary heart disease events with increasing length of follow up
Wannamethee et al.
Heart 1999;81:374-379.
ABSTRACT | FULL TEXT  

The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers
Cullen et al.
Circulation 1997;96:2128-2136.
ABSTRACT | FULL TEXT  

Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association
Fagot-Campagna et al.
Circulation 1997;96:1408-1415.
ABSTRACT | FULL TEXT  

Low Serum Cholesterol and Mortality : Which Is the Cause and Which Is the Effect?
Iribarren et al.
Circulation 1995;92:2396-2403.
ABSTRACT | FULL TEXT  

Association of Weight Loss and Weight Fluctuation with Mortality among Japanese American Men
Iribarren et al.
NEJM 1995;333:686-692.
ABSTRACT | FULL TEXT  

Low serum total cholesterol concentrations and mortality in middle aged British men
Wannamethee et al.
BMJ 1995;311:409-413.
ABSTRACT | FULL TEXT  

Lipid Lowering, Regression, and Coronary Events : A Review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council Meeting
Gotto
Circulation 1995;92:646-656.
FULL TEXT  

Serum Total Cholesterol and Mortality: Confounding Factors and Risk Modification in Japanese-American Men
Iribarren et al.
JAMA 1995;273:1926-1932.
ABSTRACT  

Serum Cholesterol Level and Mortality Due to Suicide and Trauma in the Honolulu Heart Program
Iribarren et al.
Arch Intern Med 1995;155:695-700.
ABSTRACT  

Life Expectancy Following Dietary Modification or Smoking Cessation: Estimating the Benefits of a Prudent Lifestyle
Grover et al.
Arch Intern Med 1994;154:1697-1704.
ABSTRACT  

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study
Lindenstrom et al.
BMJ 1994;309:11-15.
ABSTRACT | FULL TEXT  

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
Law et al.
BMJ 1994;308:367-372.
ABSTRACT | FULL TEXT  

Serum Cholesterol in Young Men and Cardiovascular Disease
Corvilain et al.
NEJM 1993;329:138-138.
FULL TEXT  

Plasma Cholesterol Concentration and Mortality: The Whitehall Study
Smith et al.
JAMA 1992;267:70-76.
ABSTRACT  

SERUM CHOLESTEROL AND NONCORONARY MORTALITY
JWatch General 1991;1991:5-5.
FULL TEXT